HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cheryl Nickerson-Nutter Selected Research

Folate Receptor 2

5/2021Folate Receptor Beta as a Direct and Indirect Target for Antibody-Based Cancer Immunotherapy.
1/2019Depletion of activated macrophages with a folate receptor-beta-specific antibody improves symptoms in mouse models of rheumatoid arthritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Cheryl Nickerson-Nutter Research Topics

Disease

7Rheumatoid Arthritis
01/2019 - 04/2004
5Arthritis (Polyarthritis)
04/2014 - 01/2007
5Inflammation (Inflammations)
07/2012 - 02/2008
4Psoriasis (Pustulosis Palmaris et Plantaris)
01/2019 - 02/2008
3Neoplasms (Cancer)
05/2021 - 10/2007
3Experimental Arthritis
04/2014 - 04/2004
2Pulmonary Fibrosis (Fibrosing Alveolitis)
10/2020 - 01/2020
2Fibrosis (Cirrhosis)
10/2020 - 01/2020
2Autoimmune Diseases (Autoimmune Disease)
10/2011 - 06/2011
2Disease Progression
02/2008 - 12/2003
2Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
12/2003 - 09/2003
1Wounds and Injuries (Trauma)
10/2020
1Interstitial Lung Diseases (Interstitial Lung Disease)
01/2019
1Ulcerative Colitis
01/2019
1Crohn Disease (Crohn's Disease)
01/2019
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2019
1Chronic Obstructive Pulmonary Disease (COPD)
01/2019
1Peritonitis
01/2019
1Idiopathic Pulmonary Fibrosis
01/2019
1Body Weight (Weight, Body)
11/2010
1Acute-Phase Reaction
11/2010
1Atrophy
11/2010
1Skin Diseases (Skin Disease)
02/2010
1Psoriatic Arthritis
02/2010
1Pathologic Processes
04/2007
1Edema (Dropsy)
03/2007
1Acute Disease
12/2003

Drug/Important Bio-Agent (IBA)

4CytokinesIBA
01/2020 - 02/2008
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2014 - 04/2004
4Interleukin-22 (IL-22)IBA
10/2011 - 02/2008
3Interleukin-17 (Interleukin 17)IBA
04/2014 - 02/2010
3interleukin-21 (interleukin 21)IBA
04/2014 - 04/2007
2Folate Receptor 2IBA
05/2021 - 01/2019
2CollagenIBA
10/2020 - 01/2020
2Monoclonal AntibodiesIBA
01/2019 - 07/2012
2Proteins (Proteins, Gene)FDA Link
01/2019 - 04/2007
2Interleukin-21 ReceptorsIBA
04/2014 - 04/2007
2Interleukin-6 (Interleukin 6)IBA
04/2014 - 02/2010
2Interleukin-1 (Interleukin 1)IBA
12/2011 - 10/2011
2Phosphotransferases (Kinase)IBA
10/2007 - 12/2006
1Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA
10/2020
1Folic Acid (Vitamin M)FDA LinkGeneric
01/2020
1Bleomycin (Blenoxane)FDA LinkGeneric
01/2020
1Extracellular Matrix ProteinsIBA
01/2020
1Hydroxyproline (4 Hydroxyproline)IBA
01/2020
1InterferonsIBA
04/2014
1Toll-Like Receptor 2IBA
04/2014
1AntigensIBA
04/2014
1Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
10/2011
1interleukin-22 receptor (IL-22R)IBA
10/2011
1Messenger RNA (mRNA)IBA
02/2008
1Interleukin-12 (IL 12)IBA
02/2008
1AntibodiesIBA
02/2008
1Antimicrobial PeptidesIBA
02/2008
1Interleukin-23 (Interleukin 23)IBA
02/2008
1Collagen Type II (Type II Collagen)IBA
04/2007
1CarrageenanIBA
03/2007
1P-SelectinIBA
01/2007
1apratastatIBA
04/2004
1Metalloproteases (Metalloproteinases)IBA
04/2004
1ADAM17 ProteinIBA
04/2004
1LigandsIBA
12/2003
1Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
12/2003
1Peptides (Polypeptides)IBA
12/2003
1Integrin alpha4beta1 (VLA-4)IBA
12/2003
12- ((1- (3,5- dichlorobenzenesulfonyl)pyrrolidine- 2- carbonyl)amino)- 4- (4- methyl- 2- (methyl- (2- (4- (3- o- tolylureido)phenyl)acetyl)amino)pentanoylamino)butyric acidIBA
12/2003
1Lymphotoxin-alpha (Lymphotoxin)IBA
09/2003

Therapy/Procedure

4Therapeutics
05/2021 - 02/2008
1Immunotherapy
05/2021